Looking for a Better Way to Predict Relapse in Pediatric Acute Myeloid Leukemia

"The relapse usually happens in the first two years after diagnosis, Winters says, and is much harder to treat than the original occurrence. The current method of predicting relapse involves a bone marrow sample that is tested for specific proteins that indicate the presence of cancer, but Winters is interested in a genetic test that is more accurate and can be conducted via a simple blood draw."

Read more: https://news.cuanschutz.edu/cancer-center/predict-relapse-pediatric-acute-myeloid-leukemia